2oaz: Difference between revisions

No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
High-throughput screening for inhibitors of the human metalloprotease, methionine aminopeptidase-2 (MetAP2), identified a potent class of, 3-anilino-5-benzylthio-1,2,4-triazole compounds. Efficient array and, interative synthesis of triazoles led to rapid SAR development around the, aniline, benzylthio, and triazole moeities. Evaluation of these analogs in, a human MetAP2 enzyme assay led to the identification of several, inhibitors with potencies in the 50-100 picomolar range. The deleterious, effects on inhibitor potency by methylation of the anilino-triazole, nitrogens, as well as the X-ray crystal structure of triazole 102 bound in, the active site of MetAP2, confirm the key interactions between the, triazole nitrogens, the active site cobalt atoms, and the His-231, side-chain. The structure has also provided a rationale for interpreting, SAR within the triazole series. Key aniline (2-isopropylphenyl) and sulfur, substituents (furanylmethyl) identified in the SAR studies led to the, identification of potent inhibitors (103 and 104) of endothelial cell, proliferation. Triazoles 103 and 104 also exhibited dose-dependent, activity in an aortic ring tissue model of angiogenesis highlighting the, potential utility of MetAP2 inhibitors as anticancer agents.
High-throughput screening for inhibitors of the human metalloprotease, methionine aminopeptidase-2 (MetAP2), identified a potent class of 3-anilino-5-benzylthio-1,2,4-triazole compounds. Efficient array and interative synthesis of triazoles led to rapid SAR development around the aniline, benzylthio, and triazole moeities. Evaluation of these analogs in a human MetAP2 enzyme assay led to the identification of several inhibitors with potencies in the 50-100 picomolar range. The deleterious effects on inhibitor potency by methylation of the anilino-triazole nitrogens, as well as the X-ray crystal structure of triazole 102 bound in the active site of MetAP2, confirm the key interactions between the triazole nitrogens, the active site cobalt atoms, and the His-231 side-chain. The structure has also provided a rationale for interpreting SAR within the triazole series. Key aniline (2-isopropylphenyl) and sulfur substituents (furanylmethyl) identified in the SAR studies led to the identification of potent inhibitors (103 and 104) of endothelial cell proliferation. Triazoles 103 and 104 also exhibited dose-dependent activity in an aortic ring tissue model of angiogenesis highlighting the potential utility of MetAP2 inhibitors as anticancer agents.


==About this Structure==
==About this Structure==
Line 14: Line 14:
[[Category: Methionyl aminopeptidase]]
[[Category: Methionyl aminopeptidase]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Fisher, P.W.]]
[[Category: Fisher, P W.]]
[[Category: Hofmann, G.A.]]
[[Category: Hofmann, G A.]]
[[Category: Janson, C.A.]]
[[Category: Janson, C A.]]
[[Category: Johnson, R.K.]]
[[Category: Johnson, R K.]]
[[Category: Jr., J.P.Marino.]]
[[Category: Jr., J P.Marino.]]
[[Category: Jr., T.A.Tomazek.]]
[[Category: Jr., T A.Tomazek.]]
[[Category: Kirkpatrick, R.]]
[[Category: Kirkpatrick, R.]]
[[Category: Ma, C.]]
[[Category: Ma, C.]]
[[Category: Mattern, M.]]
[[Category: Mattern, M.]]
[[Category: Meek, T.D.]]
[[Category: Meek, T D.]]
[[Category: Ryan, D.]]
[[Category: Ryan, D.]]
[[Category: Schulz, C.]]
[[Category: Schulz, C.]]
[[Category: Smith, W.W.]]
[[Category: Smith, W W.]]
[[Category: Tew, D.G.]]
[[Category: Tew, D G.]]
[[Category: Thompson, S.K.]]
[[Category: Thompson, S K.]]
[[Category: Veber, D.F.]]
[[Category: Veber, D F.]]
[[Category: Xiong, W.C.]]
[[Category: Xiong, W C.]]
[[Category: Yamamoto, Y.]]
[[Category: Yamamoto, Y.]]
[[Category: Yamashita, K.]]
[[Category: Yamashita, K.]]
Line 41: Line 41:
[[Category: methionine]]
[[Category: methionine]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jan 23 10:41:45 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 18:16:29 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA